CARE Ratings Ltd Declines 1.59%: Mixed Technical Signals and Hold Rating Shape Week

54 minutes ago
share
Share Via
CARE Ratings Ltd closed the week down 1.59% at Rs.1,718.25, underperforming the Sensex which fell 0.37% over the same period. The stock experienced a volatile week marked by a downgrade to Hold, shifting technical momentum, and mixed market signals that influenced investor sentiment and price action.

Key Events This Week

10 Aug: Stock opens at Rs.1,731.80, declines 0.82%

11 Aug: Downgrade to Hold announced amid mixed technical and valuation signals

12 Aug: Technical momentum shifts to mildly bullish but stock falls 2.15%

13 Aug: Technical momentum improves to bullish, stock rebounds 2.18%

14 Aug: Stock closes at Rs.1,718.25, down 0.51% on the day

Week Open
Rs.1,746.10
Week Close
Rs.1,718.25
-1.59%
Week High
Rs.1,731.80
vs Sensex
-1.22%

10 August 2026: Week Opens with a Decline Amid Market Stability

CARE Ratings Ltd began the week at Rs.1,731.80, down 0.82% from the previous Friday’s close of Rs.1,746.10. This decline contrasted with the Sensex’s modest gain of 0.09% to 37,131.97, signalling early weakness in the stock despite a broadly stable market. Trading volume was moderate at 4,118 shares, reflecting cautious investor positioning ahead of anticipated news.

11 August 2026: Downgrade to Hold Dampens Sentiment

On 11 August, MarketsMOJO downgraded CARE Ratings Ltd from a Buy to a Hold rating, citing mixed technical and valuation signals. The downgrade reflected concerns over the stock’s elevated price-to-book ratio of 5.4 and moderate long-term growth rates, despite strong financial fundamentals such as a net-debt-free balance sheet and a 24.81% half-yearly ROCE.

The downgrade coincided with a sharp 2.15% drop in the stock price to Rs.1,694.60, significantly underperforming the Sensex which fell 0.28% to 37,029.82. Institutional investors’ confidence remained notable with a 54.99% stake, but the market reacted cautiously to the tempered outlook and mixed technical indicators.

12 August 2026: Technical Momentum Shifts Amid Continued Price Pressure

Despite the downgrade, technical analysis on 12 August showed a shift from bullish to mildly bullish momentum. However, the stock price declined further by 0.26% to Rs.1,690.20, underperforming the Sensex’s 0.17% fall to 36,967.15. Key indicators such as the weekly MACD remained bullish, but monthly MACD turned mildly bearish, and the Relative Strength Index (RSI) showed neutral signals, indicating consolidation.

The stock traded within a range of Rs.1,680.00 to Rs.1,732.40, staying well above its 52-week low of Rs.1,393.95 but below the 52-week high of Rs.1,836.00. This price action suggested investor uncertainty amid mixed technical signals and valuation concerns.

Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!

  • - Reliable Performer certified
  • - Consistent execution proven
  • - Large Cap safety pick

Get Safe Returns →

13 August 2026: Technical Momentum Turns Bullish, Stock Rebounds

The stock showed signs of recovery on 13 August, rising 2.18% to close at Rs.1,727.10, outperforming the Sensex which gained 0.16% to 37,024.45. This rebound was supported by a shift in technical momentum to a bullish stance on weekly and daily charts, with moving averages turning positive and on-balance volume indicating accumulation.

Despite this short-term strength, monthly technical indicators remained mixed, with the MACD and Know Sure Thing (KST) oscillators mildly bearish. The stock traded within a range of Rs.1,661.00 to Rs.1,721.45, still below its 52-week high but maintaining a constructive technical posture.

14 August 2026: Week Closes with a Mild Decline Amid Mixed Signals

CARE Ratings ended the week on 14 August at Rs.1,718.25, down 0.51% from the previous day’s close. The Sensex also declined 0.17% to 36,962.93. The stock’s volume of 2,756 shares reflected moderate trading interest as investors digested the week’s developments.

The mixed technical signals and the recent downgrade to Hold continued to weigh on sentiment, despite the company’s strong financial fundamentals and institutional backing. The stock’s weekly decline of 1.59% contrasted with the Sensex’s smaller fall of 0.37%, indicating relative underperformance.

Considering CARE Ratings Ltd? Wait! SwitchER has found potentially better options in and beyond. Compare this small-cap with top-rated alternatives now!

  • - Better options discovered
  • - + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Date Stock Price Day Change Sensex Day Change
2026-08-10 Rs.1,731.80 -0.82% 37,131.97 +0.09%
2026-08-11 Rs.1,694.60 -2.15% 37,029.82 -0.28%
2026-08-12 Rs.1,690.20 -0.26% 36,967.15 -0.17%
2026-08-13 Rs.1,727.10 +2.18% 37,024.45 +0.16%
2026-08-14 Rs.1,718.25 -0.51% 36,962.93 -0.17%

Key Takeaways

Financial Strength Amidst Valuation Concerns: CARE Ratings maintains a net-debt-free balance sheet, strong operating cash flow of ₹147.57 crores, and a half-yearly ROCE of 24.81%. However, its elevated P/B ratio of 5.4 and moderate long-term growth rates temper enthusiasm.

Technical Momentum Mixed but Improving: The stock’s technical indicators shifted from bullish to mildly bullish early in the week, then to bullish by midweek, supported by daily moving averages and volume trends. Monthly indicators remain cautious, reflecting a consolidation phase.

Market Reaction to Downgrade: The downgrade to Hold by MarketsMOJO on 11 August triggered a notable price decline, with the stock underperforming the Sensex throughout the week. This reflects investor caution despite the company’s solid fundamentals.

Conclusion

CARE Ratings Ltd’s week was characterised by a cautious market response to a downgrade amid mixed technical signals and valuation concerns. While the company’s financial health remains robust, the stock’s price action reflected uncertainty, resulting in a 1.59% weekly decline that outpaced the Sensex’s 0.37% fall. Technical momentum showed signs of recovery midweek but was insufficient to sustain gains through Friday. Investors should consider the balance between strong fundamentals and tempered growth prospects, alongside evolving technical trends, when assessing CARE Ratings’ near-term outlook.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News